Advertisement

Latest News

FDA Proposes Exclusion of Multiple GLP-1 RAs from Bulks List, With Raechel Sood, NP

18 minutes ago

Sood shares her thoughts on the recent announcement by the FDA, limiting pharmacies’ ability to compound semaglutide, tirzepatide, and liraglutide from bulk substances.

APOL1-Mediated Kidney Disease: From Genetic Discovery to the Edge of Precision Medicine

1 hour ago

APOL1 research is driving precision nephrology, but prediction gaps and equity challenges still limit clinical impact.

BGF Triple Therapy FDA Approval Expands Asthma Options for Underserved Patients, With Juanita Mora, MD

3 hours ago

The first single-inhaler ICS/LABA/LAMA combination for asthma adds a mechanistically distinct bronchodilator to a well-established inhaled backbone.

5 Psychiatry Headlines You Missed in April 2026

3 hours ago

FDA expands lumateperone for relapse prevention in schizophrenia, White House boosts psychedelics research, and AI reshapes psychiatry care debates in April 2026.

5 Pulmonology Headlines You Missed in April 2026

5 hours ago

April 2026 saw new data from pivotal clinical trials and a new approval in asthma.

Advertisement
Advertisement